News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Stressgen Biotechnologies Corporation (SSB.TO) To Present At Upcoming BioFinance 2006 Conference In Toronto


5/3/2006 10:21:32 AM

SAN DIEGO, CA, May 2 /PRNewswire-FirstCall/ - Stressgen Biotechnologies Corporation today announced that Gregory M. McKee, President and Chief Executive Officer, will present a corporate update at the BioFinance 2006 Conference on Wednesday, May 3, 2006, at 10:00 am ET at the Toronto Marriott Eaton Centre Hotel in Toronto.

About Stressgen Biotechnologies Corporation:

--------------------------------------------

Stressgen is developing innovative therapeutics for the treatment of viral infections, with a focus on diseases caused by the human papillomavirus (HPV). The corporation is publicly traded on the Toronto Stock Exchange under the symbol SSB. For more information about Stressgen, please visit the website located at www.stressgen.com.

Donna Slade Director, Investor Relations 6055 Lusk Boulevard San Diego, CA USA 92121 Tel: 858.202.4900 Dir: 858.202.4945 dslade@stressgen.com

Stressgen Biotechnologies Corp.

CONTACT: Donna Slade, Director, Investor Relations, 6055 Lusk Boulevard,San Diego, CA, USA, 92121, Tel: (858) 202-4900, Dir: (858) 202-4945,dslade@stressgen.com


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES